Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 117.7 Million EUR | -22.59% |
| 2022 | 152.05 Million EUR | -7.69% |
| 2021 | 164.71 Million EUR | -40.84% |
| 2020 | 278.43 Million EUR | 152.68% |
| 2019 | 110.19 Million EUR | 0.0% |
| 2018 | - EUR | -100.0% |
| 2017 | 142.49 Million EUR | 3.71% |
| 2016 | 137.39 Million EUR | 3.67% |
| 2015 | 132.52 Million EUR | -24.91% |
| 2014 | 176.49 Million EUR | -7.71% |
| 2013 | 191.23 Million EUR | 107.78% |
| 2012 | 92.03 Million EUR | -52.98% |
| 2011 | 195.74 Million EUR | -31.99% |
| 2010 | 287.79 Million EUR | -35.66% |
| 2009 | 447.28 Million EUR | -2.99% |
| 2008 | 461.08 Million EUR | 12.51% |
| 2007 | 409.82 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 73.67 Million EUR | 0.0% |
| 2024 Q1 | 102.5 Million EUR | -16.61% |
| 2023 Q4 | 117.7 Million EUR | 0.0% |
| 2023 Q1 | 134.7 Million EUR | -11.41% |
| 2023 Q3 | 117.7 Million EUR | -12.62% |
| 2023 Q2 | 134.7 Million EUR | 0.0% |
| 2023 FY | 117.7 Million EUR | -22.59% |
| 2022 Q3 | 152.05 Million EUR | 7.63% |
| 2022 Q4 | 152.05 Million EUR | 0.0% |
| 2022 FY | 152.05 Million EUR | -7.69% |
| 2022 Q1 | 141.28 Million EUR | -14.23% |
| 2022 Q2 | 141.28 Million EUR | 0.0% |
| 2021 Q2 | 269.23 Million EUR | 0.0% |
| 2021 Q3 | 164.71 Million EUR | -38.82% |
| 2021 Q1 | 269.23 Million EUR | -3.3% |
| 2021 Q4 | 164.71 Million EUR | 0.0% |
| 2021 FY | 164.71 Million EUR | -40.84% |
| 2020 Q1 | 39.38 Million EUR | -64.25% |
| 2020 Q3 | 278.43 Million EUR | 606.87% |
| 2020 Q2 | 39.38 Million EUR | 0.0% |
| 2020 FY | 278.43 Million EUR | 152.68% |
| 2020 Q4 | 278.43 Million EUR | 0.0% |
| 2019 Q1 | 113.71 Million EUR | 0.0% |
| 2019 Q3 | 110.19 Million EUR | -3.1% |
| 2019 Q2 | 113.71 Million EUR | 0.0% |
| 2019 FY | 110.19 Million EUR | 0.0% |
| 2019 Q4 | 110.19 Million EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 FY | - EUR | -100.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 Q2 | 139.88 Million EUR | 0.0% |
| 2017 Q1 | 139.88 Million EUR | 1.81% |
| 2017 FY | 142.49 Million EUR | 3.71% |
| 2017 Q4 | 142.49 Million EUR | 0.0% |
| 2017 Q3 | 142.49 Million EUR | 1.86% |
| 2016 Q1 | 134.91 Million EUR | 1.8% |
| 2016 FY | 137.39 Million EUR | 3.67% |
| 2016 Q4 | 137.39 Million EUR | 0.0% |
| 2016 Q3 | 137.39 Million EUR | 1.84% |
| 2016 Q2 | 134.91 Million EUR | 0.0% |
| 2015 Q3 | 131.34 Million EUR | 0.9% |
| 2015 Q4 | 132.52 Million EUR | 0.9% |
| 2015 Q2 | 130.16 Million EUR | 0.89% |
| 2015 FY | 132.52 Million EUR | -24.91% |
| 2015 Q1 | 129.02 Million EUR | -26.89% |
| 2014 Q3 | 185.27 Million EUR | 45.97% |
| 2014 Q4 | 176.49 Million EUR | -4.74% |
| 2014 Q1 | 201.05 Million EUR | 5.14% |
| 2014 FY | 176.49 Million EUR | -7.71% |
| 2014 Q2 | 126.92 Million EUR | -36.87% |
| 2013 Q4 | 191.23 Million EUR | 5.73% |
| 2013 FY | 191.23 Million EUR | 107.78% |
| 2013 Q3 | 180.86 Million EUR | -5.2% |
| 2013 Q2 | 190.79 Million EUR | 63.22% |
| 2013 Q1 | 116.89 Million EUR | 27.01% |
| 2012 Q2 | 104.92 Million EUR | -49.01% |
| 2012 Q4 | 92.03 Million EUR | -19.29% |
| 2012 FY | 92.03 Million EUR | -52.98% |
| 2012 Q1 | 205.79 Million EUR | 5.14% |
| 2012 Q3 | 114.02 Million EUR | 8.68% |
| 2011 FY | 195.74 Million EUR | -31.99% |
| 2011 Q1 | 283.26 Million EUR | -1.57% |
| 2011 Q2 | 216.45 Million EUR | -23.59% |
| 2011 Q3 | 206.74 Million EUR | -4.49% |
| 2011 Q4 | 195.74 Million EUR | -5.32% |
| 2010 FY | 287.79 Million EUR | -35.66% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q4 | 287.79 Million EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2009 Q4 | 447.28 Million EUR | 0.0% |
| 2009 FY | 447.28 Million EUR | -2.99% |
| 2008 FY | 461.08 Million EUR | 12.51% |
| 2007 FY | 409.82 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 83.311% |
| Ansell Limited | 706.6 Million USD | 83.342% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -425.193% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -18732.64% |
| ConvaTec Group Plc | 1.22 Billion USD | 90.393% |
| ConvaTec Group Plc | 1.22 Billion USD | 90.406% |
| Encision Inc. | 67.33 Thousand USD | -174700.998% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -30645.2% |
| LifePoint, Inc. | 151.73 Thousand USD | -77472.594% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -2295.279% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -19038.862% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -65304.555% |
| SmileDirectClub, Inc. | 849.37 Million USD | 86.142% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 44.158% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -242643.715% |
| Vasamed, Inc. | 18.95 Thousand USD | -621029.288% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -637240.264% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -30046.115% |